Clinical trial
Asimadoline for the Treatment of Post-Operative Ileus
NCT00443040 · Tioga Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00443040 |
|---|---|
| Title | Asimadoline for the Treatment of Post-Operative Ileus |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study Evaluating Asimadoline on the Duration of POI in Subjects Undergoing Laparoscopic/Hand-Assisted Lap Segmental Colonic Resection Secondary to Colon Cancer, Polypectomy or Diverticulitis |
| Lead sponsor | Tioga Pharmaceuticals, Industry |
| Collaborators | RTI Health Solutions |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Post-Operative Ileus |
| Intervention type | Drug |
| Interventions | Asimadoline, Placebo |
| Enrollment | 35 |
| Start date | Jan 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Mar 5, 2007 |
| Last update posted | Jan 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: